![Yi-Wu Vincent Xie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi-Wu Vincent Xie
Geen lopende functies
Profiel
Yi-Wu Vincent Xie served as the Chief Technology Officer at China Biologic Products, Inc. before obtaining a doctorate degree from New York Medical College and an undergraduate degree from Sun Yat-Sen University.
Eerdere bekende functies van Yi-Wu Vincent Xie
Bedrijven | Functie | Einde |
---|---|---|
China Biologic Products, Inc.
![]() China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Yi-Wu Vincent Xie
Sun Yat-Sen University | Undergraduate Degree |
New York Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
China Biologic Products, Inc.
![]() China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |